ARYZTA Confronts Its German Problem with a Strategic Review — and a Capital Return on the Horizon
H1 organic growth turns negative as Germany drags; management accelerates cost savings, weighs exit options, and signals 2027 shareholder returns.
ARYN.SW · Earnings Call · 2026-08-10
H1: A Resilient but Shrinking Top Line
ARYZTA's first half of fiscal 2026 was a study in resilience under pressure. Revenue came in at EUR 1,063.9 million, a 2.1% reported decline and 2.7% organic decline, with negative pricing only partially offset by a modest FX tailwind. EBITDA margin slipped 70 basis points to 13.2%, including ~50 basis points of one-time costs from the Excellence Programme. Free cash flow remained solid at EUR 23.6 million, and the company continued to de-lever, reducing net debt by nearly EUR 100 million to EUR 789 million (2.7x EBITDA). Germany is the clear culprit. As “Urs Jordi put it, "In Germany, the market for H1 for bakery products was short by -1% in value and -4%, -5% in volume."” — Urs Jordi, Chairman and Interim CEO · 2026-08-10 The decline is amplified by insourcing from large retail customers who are using their own capacity when volumes fall. “If the market is short, the addressable market for the suppliers, it's becoming less because some big customers are then re-insourcing products in their own manufacturing,” — Urs Jordi, Chairman and Interim CEO · 2026-08-10 Jordi explained. That's not a mix shift ARYZTA can simply price away.Strategic Response: Everything Is on the Table
Management's response is twofold: accelerate cost savings and put Germany under the microscope. The Excellence Programme is already hitting 45% of production volume, with confirmed gross reductions of EUR 8–10 million. But the more dramatic development is the explicit statement that “we have decided that we will study all options for the German businesses” — Martin Huber, Chief Financial Officer (CFO) · 2026-08-10 — a review Martin Huber expects to conclude “sometime in the second half of this year.” — Martin Huber, Chief Financial Officer (CFO) · 2026-08-10 This is a notable pivot. In the prior earnings call (March 2026), management talked about improving retail performance but did not flag a potential exit or restructuring. The shift suggests the board is seriously weighing the future of its largest market.The review has financial implications. Closing or exiting German capacity would incur significant one-time costs and potentially asset write-downs, which could delay the capital return program. Yet management reiterated its intention to propose dividends or buybacks at the 2027 AGM, pointing to a stronger balance sheet: “Our core equity continues to increase to 23.3% of total assets, up from 18% in previous year.” — Martin Huber, Chief Financial Officer (CFO) · 2026-08-10 This is part of a longer-term trajectory; in the prior call, Martin Huber had set a target of reaching closer to 30% core equity by year-end. The Excellence Programme itself is a key driver of the margin recovery. In the prior call, Urs Jordi affirmed the plan's scope: “We are in process to finish this program in Switzerland. The next approach we will take in Germany.” — Urs Jordi, CEO · 2026-03-02 While that statement now seems almost prescient, the current urgency is clearly elevated. Martin Huber also underscored the consistent cash-generation outlook: “I would expect continued strong cash flow generation and I would not expect a change of the deliveries that we have been able to bring forward.” — Martin Huber, CFO · 2026-03-02We are making sure that we are ahead of the curve and address the points in order to fix the performance and maximize the overall value creation of our business.